STAT3 and acute kidney injury: To assess the therapeutic efficacy of Stat3 inhibition in AKI mouse models, AAV9 with a Stat3 silencing plasmid controlled by a renal tubular cell-specific promoter was used for targeted Stat3 suppression in murine kidney tubular cells (Fig. 7a–b and Figure S8a–b).